Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Stem Cells | 3 | 2022 | 1376 | 0.620 |
Why?
|
| Blast Crisis | 1 | 2015 | 103 | 0.520 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2022 | 3524 | 0.490 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2015 | 651 | 0.400 |
Why?
|
| Antigens, CD | 1 | 2015 | 4026 | 0.250 |
Why?
|
| Pyrimidinones | 2 | 2021 | 370 | 0.200 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2024 | 2938 | 0.180 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2021 | 182 | 0.180 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2022 | 671 | 0.160 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2021 | 640 | 0.150 |
Why?
|
| Deoxycytidine | 1 | 2021 | 826 | 0.140 |
Why?
|
| Sulfonamides | 2 | 2022 | 1940 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2015 | 23404 | 0.130 |
Why?
|
| STAT Transcription Factors | 1 | 2015 | 182 | 0.120 |
Why?
|
| Janus Kinases | 1 | 2015 | 244 | 0.120 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 1378 | 0.120 |
Why?
|
| Pyrazoles | 2 | 2021 | 1972 | 0.120 |
Why?
|
| Antigens, CD34 | 1 | 2015 | 659 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2021 | 4222 | 0.100 |
Why?
|
| Immunophenotyping | 1 | 2015 | 1880 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 3799 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 1525 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2015 | 2504 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2504 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2024 | 1434 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 5534 | 0.070 |
Why?
|
| Multiple Myeloma | 1 | 2022 | 5181 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 4839 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11525 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2022 | 12207 | 0.050 |
Why?
|
| CDC2 Protein Kinase | 1 | 2022 | 220 | 0.050 |
Why?
|
| Cytokines | 1 | 2015 | 7323 | 0.050 |
Why?
|
| Survival | 1 | 2021 | 163 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 13693 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 9445 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2022 | 1794 | 0.040 |
Why?
|
| Phenotype | 1 | 2015 | 16367 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2022 | 783 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 1656 | 0.030 |
Why?
|
| Aniline Compounds | 1 | 2021 | 986 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 16690 | 0.030 |
Why?
|
| Canada | 1 | 2021 | 2065 | 0.030 |
Why?
|
| Pyrazines | 1 | 2021 | 1230 | 0.030 |
Why?
|
| RNA Interference | 1 | 2022 | 2890 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3554 | 0.030 |
Why?
|
| Humans | 7 | 2024 | 744366 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 57776 | 0.020 |
Why?
|
| Child | 1 | 2015 | 77709 | 0.020 |
Why?
|
| Apoptosis | 1 | 2024 | 9724 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2021 | 12025 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 213390 | 0.020 |
Why?
|
| Mice | 2 | 2024 | 81201 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8432 | 0.020 |
Why?
|
| Female | 3 | 2021 | 380193 | 0.020 |
Why?
|
| Aged | 1 | 2015 | 163288 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 214052 | 0.010 |
Why?
|
| Animals | 2 | 2024 | 168768 | 0.010 |
Why?
|
| Male | 1 | 2015 | 350115 | 0.010 |
Why?
|
| United States | 1 | 2021 | 69872 | 0.010 |
Why?
|
Concepts
(59)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_